NCT04170478View on ClinicalTrials.gov

Transperineal Laser Ablation for Focal Treatment of Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

October 15, 2021

Study Completion Date

October 15, 2021

Conditions
Prostate CancerFocal Laser AblationTransperineal Laser Ablation
Interventions
DEVICE

Echolaser X4 system

Transperineal laser ablation

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
collaborator

Elesta S.R.L.

INDUSTRY

collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

The Netherlands Cancer Institute

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT04170478 - Transperineal Laser Ablation for Focal Treatment of Prostate Cancer | Biotech Hunter | Biotech Hunter